{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T21:05:49Z","timestamp":1776287149205,"version":"3.50.1"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Facioscapulohumeral muscular dystrophy type 1 (FSHD1) is one of the most common forms of autosomal-dominant muscular dystrophies characterized by variable disease penetrance due to shortened D4Z4 repeat units on 4q35. The molecular diagnosis of FSHD1 is usually made by Southern blotting, which is complex, time-consuming, and lacks clinical practicality. Therefore, in this study, optical genome mapping (OGM) is employed for the genetic diagnosis of FSHD1. Furthermore, epigenetic heterogeneity is determined from methylation analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Genomic DNA samples from four members of the same family were subjected to whole-exome sequencing. OGM was used to identify structural variations in D4Z4, while sodium bisulfite sequencing helped identify the methylation levels of CpG sites in a region located distally to the D4Z4 array. A multidisciplinary team collected the clinical data, and comprehensive family analyses aided in the assessment of phenotypes and genotypes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Whole-exome sequencing did not reveal variants related to clinical phenotypes in the patients. OGM showed that the proband was a compound heterozygote for the 4qA allele with four and eight D4Z4 repeat units, whereas the affected younger brother had only one 4qA allele with four D4Z4 repeat units. Both the proband and her younger brother were found to display asymmetric weakness predominantly involving the facial, shoulder girdle, and upper arm muscles, whereas the younger brother had more severe clinical symptoms. The proband's father, who was found to be normal after a neurological examination, also carried the 4qA allele with eight D4Z4 repeat units. The unaffected mother exhibited 49 D4Z4 repeat units of the 4qA allele and a minor mosaic pattern with four D4Z4 repeat units of the 4qA allele. Consequently, the presence of the 4qA allele in the four D4Z4 repeat units strongly pointed to the occurrence of maternal germline mosaicism. The CpG6 methylation levels were lower in symptomatic patients compared to those in the asymptomatic parents. The older sister had lower clinical scores and ACSS and higher CpG6 methylation levels than that of her younger brother.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In this study, two siblings with FSHD1 with phenotypically normal parents were identified by OGM. Our findings suggest that the 4qA allele of four D4Z4 repeats was inherited through maternal germline mosaicism. The clinical phenotype heterogeneity is influenced by the CpG6 methylation levels. The results of this study greatly aid in the molecular diagnosis of FSHD1 and in also understanding the clinical phenotypic variability underlying the disease.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2024.1258831","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T04:36:00Z","timestamp":1706762160000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Case report: Identification of facioscapulohumeral muscular dystrophy 1 in two siblings with normal phenotypic parents using optical genome mapping"],"prefix":"10.3389","volume":"15","author":[{"given":"Jieni","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaotang","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haibo","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiantian","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuemei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,2,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000797","article-title":"Population-based incidence and prevalence of facioscapulohumeral dystrophy","author":"Deenen","year":"2014","journal-title":"Neurology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1002\/cphy.c160039","article-title":"Facioscapulohumeral muscular dystrophy","volume":"7","author":"DeSimone","year":"2017","journal-title":"Compr Physiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/ng0992-26","article-title":"Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy","volume":"2","author":"Wijmenga","year":"1992","journal-title":"Nat Genet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1126\/science.1189044","article-title":"A unifying genetic model for facioscapulohumeral muscular dystrophy","volume":"329","author":"Lemmers","year":"2010","journal-title":"Science."},{"key":"B5","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/0960-8966(93)90102-P","article-title":"Molecular genetics of facioscapulohumeral muscular dystrophy","volume":"3","author":"Wijmenga","year":"1993","journal-title":"Neuromuscul Disord"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/ng.2454","article-title":"Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2","volume":"44","author":"Lemmers","year":"2012","journal-title":"Nat Genet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.ajhg.2016.03.013","article-title":"Mutations in DNMT3B modify epigenetic repression of the d4z4 repeat and the penetrance of facioscapulohumeral dystrophy","volume":"98","author":"van den Boogaard","year":"2016","journal-title":"Am J Hum Genet"},{"key":"B8","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1002\/ana.10057","article-title":"Complete allele information in the diagnosis of facioscapulohumeral muscular dystrophy by triple DNA analysis","volume":"50","author":"L","year":"2001","journal-title":"Ann Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s10048-019-00575-4","article-title":"Facioscapulohumeral muscular dystrophy (FSHD) molecular diagnosis: from traditional technology to the NGS era","volume":"20","author":"Zampatti","year":"2019","journal-title":"Neurogenetics."},{"key":"B10","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.nmd.2023.04.005","article-title":"268th ENMC workshop participants","volume":"33","author":"Montagnese","year":"2023","journal-title":"Neuromuscul Disord."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e629","DOI":"10.1002\/cpz1.629","article-title":"Testing for facioscapulohumeral muscular dystrophy with optical genome mapping","volume":"3","author":"Koppikar","year":"2023","journal-title":"Curr Protoc."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1016\/j.jmoldx.2021.07.021","article-title":"Validation of optical genome mapping for the molecular diagnosis of facioscapulohumeral muscular dystrophy","volume":"23","author":"Stence","year":"2021","journal-title":"J Mol Diagn."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1212\/01.wnl.0000271391.44352.fe","article-title":"Hypomethylation is restricted to theD4Z4 repeat array in phenotypic FSHD","volume":"69","author":"de Greef","year":"2007","journal-title":"Neurology."},{"key":"B14","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/1531-8249(199906)45:6<751::AID-ANA9>3.0.CO;2-M","article-title":"Progress in the molecular diagnosis of facioscapulohumeral muscular dystrophy and correlation between the number of KpnI repeats at the 4q35 locus and clinical phenotype","volume":"45","author":"Ricci","year":"1999","journal-title":"Ann Neurol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/ana.20625","article-title":"Variable hypomethylation of D4Z4 in facioscapulohumeral muscular dystrophy","volume":"58","author":"van Overveld","year":"2005","journal-title":"Ann Neurol."},{"key":"B16","volume-title":"Bionano Solve Theory of Operation: Bionano EnFocusTM FSHD Analysis","author":"Bionano","year":"2021"},{"key":"B17","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1136\/jmedgenet-2015-103436","article-title":"Allele-specific DNA hypomethylation characterises FSHD1 and FSHD2","volume":"53","author":"Calandra","year":"2016","journal-title":"J Med Genet."},{"key":"B18","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1136\/jmedgenet-2019-106078","article-title":"Single-molecule optical mapping enables quantitative measurement of D4Z4 repeats in facioscapulohumeral muscular dystrophy (FSHD)","volume":"57","author":"Dai","year":"2020","journal-title":"J Med Genet."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1002\/humu.23304","article-title":"Molecular combing reveals complex 4q35 rearrangements in Facioscapulohumeral dystrophy","volume":"38","author":"Nguyen","year":"2017","journal-title":"Hum Mutat."},{"key":"B20","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.nmd.2015.08.008","article-title":"Molecular combing compared to Southern blot for measuring D4Z4 contractions in FSHD","volume":"25","author":"Vasale","year":"2015","journal-title":"Neuromuscul Disord."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e0151963","DOI":"10.1371\/journal.pone.0151963","article-title":"Filling in the gap of human chromosome 4: single molecule real time sequencing of macrosatellite repeats in the facioscapulohumeral muscular dystrophy locus","volume":"11","author":"Morioka","year":"2016","journal-title":"PLoS ONE."},{"key":"B22","doi-asserted-by":"publisher","first-page":"14789","DOI":"10.1038\/s41598-017-13712-6","article-title":"Nanopore-based single molecule sequencing of the D4Z4 array responsible for facioscapulohumeral muscular dystrophy","volume":"7","author":"Mitsuhashi","year":"2017","journal-title":"Sci Rep"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e007798","DOI":"10.1136\/bmjopen-2015-007798","article-title":"Clinical expression of facioscapulohumeral muscular dystrophy in carriers of 1-3 D4Z4 reduced alleles: experience of the FSHD Italian National Registry","volume":"6","author":"Nikolic","year":"2016","journal-title":"BMJ Open"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1212\/WNL.0000000000002217","article-title":"Milder phenotype in facioscapulohumeral dystrophy with 7-10 residual D4Z4 repeats","volume":"85","author":"Statland","year":"2015","journal-title":"Neurology."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e204040","DOI":"10.1001\/jamanetworkopen.2020.4040","article-title":"Phenotypic variability among patients with d4z4 reduced allele facioscapulohumeral muscular dystrophy","volume":"3","author":"Ruggiero","year":"2020","journal-title":"JAMA Netw Open"},{"key":"B26","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1212\/WNL.61.7.909","article-title":"Possible phenotypic dosage effect in patients compound heterozygous for FSHD-sized 4q35 alleles","volume":"61","author":"Wohlgemuth","year":"2003","journal-title":"Neurology."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e225","DOI":"10.1212\/WNL.0000000000207418","article-title":"Association of 4qA-specific distal D4Z4 hypomethylation with disease severity and progression in facioscapulohumeral muscular dystrophy","volume":"101","author":"Zheng","year":"2023","journal-title":"Neurology."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1136\/jmg.2003.008755","article-title":"Very low penetrance in 85 Japanese families with facioscapulohumeral muscular dystrophy 1A","volume":"41","author":"Goto","year":"2004","journal-title":"J Med Genet."},{"key":"B29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.nmd.2003.07.001","article-title":"Asymptomatic carriers and gender differences in facioscapulohumeral muscular dystrophy (FSHD)","volume":"14","author":"Tonini","year":"2004","journal-title":"Neuromuscul Disord."},{"key":"B30","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.1093\/brain\/awt226","article-title":"Large scale genotype\u2013phenotype analyses indicate that novel prognostic tools are required for families with facioscapulohumeral muscular dystrophy","volume":"136","author":"Ricci","year":"2013","journal-title":"Brain"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13023-014-0218-1","article-title":"Low penetrance in facioscapulohumeral muscular dystrophy type 1 with large pathological D4Z4 alleles: a cross-sectional multicenter study","volume":"10","author":"Salort-Campana","year":"2015","journal-title":"Orphanet J Rare Dis."},{"key":"B32","doi-asserted-by":"crossref","DOI":"10.1002\/(SICI)1096-8628(19980501)77:2<155::AID-AJMG9>3.0.CO;2-R","article-title":"The facioscapulohumeral muscular dystrophy (FSHD1) gene affects males more severely and more frequently than females","author":"Zatz","year":"1998","journal-title":"Am J Med Genet"},{"key":"B33","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/978-3-319-70178-3_9","article-title":"Sex differences in muscle wasting","volume":"1043","author":"Anderson","year":"2017","journal-title":"Adv Exp Med Biol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/978-3-319-70178-3_2","article-title":"Sex differences in body composition","volume":"1043","author":"Bredella","year":"2017","journal-title":"Adv Exp Med Biol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1097\/SPC.0000000000000355","article-title":"Muscle pain syndromes and fibromyalgia: the role of muscle biopsy","volume":"12","author":"Ruggiero","year":"2018","journal-title":"Curr Opin Support Palliat Care."},{"key":"B36","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1212\/WNL.0000000000000708","article-title":"Differential DNA methylation of the D4Z4 repeat in patients with FSHD and asymptomatic carriers","volume":"83","author":"Gaillard","year":"2014","journal-title":"Neurology."},{"key":"B37","unstructured":"PhD ThesisFacioscapulohumeral Disease1982"},{"key":"B38","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1086\/302730","article-title":"De novo facioscapulohumeral muscular dystrophy: frequent somatic mosaicism, sex-dependent phenotype, and the role of mitotic transchromosomal repeat interaction between chromosomes 4 and 10","volume":"66","author":"van der Maarel","year":"2000","journal-title":"Am J Hum Genet."},{"key":"B39","first-page":"99","article-title":"High proportion of new mutations and possible anticipation in Brazilian facioscapulohumeral muscular dystrophy families","volume":"56","author":"Zatz","year":"1995","journal-title":"Am J Hum Genet."},{"key":"B40","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s004390050244","article-title":"Germline mosaicism in 4q35 facioscapulohumeral muscular dystrophy (FSHD1A) occurring predominantly in oogenesis","volume":"98","author":"K\u00f6hler","year":"1996","journal-title":"Hum Genet."},{"key":"B41","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1002\/mus.880181315","article-title":"Facioscapulohumeral muscular dystrophy in the Dutch population","volume":"2","author":"Padberg","year":"1995","journal-title":"Muscle Nerve Suppl"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/mus.880181310","article-title":"Germinal mosaicism in facioscapulohumeral muscular dystrophy (FSHD)","author":"Upadhyaya","year":"1995","journal-title":"Muscle Nerve Suppl"},{"key":"B43","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1002\/ana.20106","article-title":"Somatic mosaicism in FSHD often goes undetected","volume":"55","author":"Lemmers","year":"2004","journal-title":"Ann Neurol."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1258831\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T04:36:05Z","timestamp":1706762165000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1258831\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,1]]},"references-count":43,"alternative-id":["10.3389\/fneur.2024.1258831"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2024.1258831","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,1]]},"article-number":"1258831"}}